[Federal Register Volume 63, Number 172 (Friday, September 4, 1998)]
[Notices]
[Page 47322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-23833]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 7, 1998, and published in the Federal Register 
on May 19, 1998, (63 FR 27590) Roche Diagnostic Systems, Inc., 1080 
U.S. Highway 202, Somerville, New Jersey 08876-3771), made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I                          
Tetrahydrocannabinols (7370)...............  I                          
Phencyclidine (7471).......................  II                         
Benzoylecgonine (9180).....................  II                         
Methadone (9250)...........................  II                         
Morphine (9300)............................  II                         
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances for incorporation in drug of abuse detection 
kits.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Roche Diagnostic Systems, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Roche Diagnostic 
Systems, Inc. on a regular basis to ensure that the company's continued 
registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.

    Dated: August 21, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-23833 Filed 9-3-98; 8:45 am]
BILLING CODE 4410-09-M